Skip to main content

Table 2 Kawasaki features and associated symptoms of Kawasaki disease shock syndrome and Kawasaki disease

From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study

 

KDSS(n=13)

KD(n=91)

P value

Kawasaki features

 Conjunctival injection

92.3% (12/13)

91.2% (83/91)

1.000

 Oropharyngeal changes

84.6% (11/13)

81.3% (74/91)

1.000

 Polymorphous rash

76.9% (10/13)

84.6% (77/91)

0.442

 Cervical lymphadenopathy

69.2% (9/13)

44.0% (40/91)

0.088

 Extremity changes

92.3% (12/13)

67.0% (61/91)

0.102

Associated symptoms

 Gastrointestinal symptoms

84.6% (11/13)

26.4% (24/91)

0.000

 Respiratory symptoms

76.9% (10/13)

9.9% (9/91)

0.000

 Neurologic symptoms

15.4% (2/13)

2.2% (2/91)

0.066

 Systemic pain

53.8% (7/13)

3.3% (3/91)

0.000

Pleural effusion

76.9% (10/13)

2.2% (2/91)

0.000

Organ damage

92.3% (12/13)

20.9%(19/91)

0.000

  1. KD Kawasaki disease, KDSS Kawasaki disease shock syndrome, SS Septic shock and toxic shock syndrome